What is Injectable Tirzepatide and How Does It Work?
About Tirzepatide
Tirzepatide is a medication that acts on two hormone pathways in the body, GLP-1 and GIP. These pathways are involved in appetite regulation, digestion, and blood sugar processes. Tirzepatide may play a role in supporting these functions when used under the guidance of a licensed healthcare provider.
FDA-Approved Products vs. Compounded Tirzepatide
Certain tirzepatide products have been approved by the FDA for specific medical uses. These FDA-approved medications have been evaluated in clinical trials for safety and effectiveness only for their approved indications. Clinical studies of FDA-approved tirzepatide products apply only to those medications. Compounded tirzepatide has not been evaluated by the FDA and may differ in formulation, strength, or quality. Compounded medications are prepared by licensed compounding pharmacies when a provider determines they are appropriate for an individual’s needs.
How It’s Taken
Tirzepatide is administered as a once-weekly subcutaneous injection (under the skin).
Your healthcare provider will:
- Determine the appropriate dosage
- Provide instructions on how to administer the injection
- Advise you on rotation of injection sites (commonly the abdomen, thigh, or upper arm)
If possible, take your injections on the same day each week to maintain a consistent schedule.
Your provider will monitor your treatment to ensure it aligns with your medical history and goals.
If you miss a dose or are unsure when your next injection should be taken, contact your healthcare provider for guidance.
Compounded versions of tirzepatide are not FDA-approved. The FDA has not evaluated compounded tirzepatide for safety, effectiveness, or quality. Compounded medications may differ in formulation, strength, or supporting evidence from FDA-approved products.
This article is for general informational purposes only and does not provide medical advice, diagnosis or treatment for any specific person.